Fabian Dörr

14PUBLICATIONS
47CO-AUTHORS
Predictive and prognostic markersParticle physicsOncology and carcinogenesis not elsewhere classifiedCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 28, 2026
Impact of COPD on Outcomes After Pulmonary Metastasectomy: A Propensity-Score Matched Analysis.

|Mar 28, 2026
Radiation Dose-Dependent and -Independent Pulmonary Infiltrates in Patients with High-Grade Pneumonitis After Radiochemotherapy and Durvalumab Consolidation for Stage III NSCLC.

Andreas Herz, Aymane Khouya, Maja Guberina

|Oct 28, 2025
Dual HDAC and PI3K Inhibitor CUDC-907 Inhibits Growth of Pleural Mesothelioma: The Impact of Cisplatin Sensitivity and Myc Expression.

Luca Hegedüs, Silvia Qaisieh, Christian Stülpnagel

|Mar 26, 2025
Non-Small Cell Lung Cancer Patients with Skip-N2 Metastases Have Similar Survival to N1 Patients-A Multicenter Analysis.

Georg Schlachtenberger, Simon Schallenberg, Fabian Doerr

|Feb 25, 2025
Is CK7 a Prognostic Marker in Pulmonary LCNEC? Evidence from a Limited Cohort Study.

Hruy Menghesha, Donatas Zalepugas, Amina Camo

|Feb 25, 2025
BCL-B Promotes Lung Cancer Invasiveness by Direct Inhibition of BOK.

Palaniappan Ramesh, Amal R Al Kadi, Gaurav M Borse

Pageof 3

Frequent Collaborators

8 joint publications

Martin Schuler

6 joint publications

Georg Schlachtenberger

6 joint publications

Servet Bölükbas

5 joint publications

Alexander Quaas